André Vuilliomenet

Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial

Thomas Pilgrim, Dik Heg, Marco Roffi et al. · The Lancet · 2014 · 263 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Percutaneous Coronary Revascularisation +7

N-terminal Pro Brain Natriuretic Peptide-Guided Management in Patients with Heart Failure and Preserved Ejection Fraction: Findings from the Trial of Intensified Versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure (TIME-CHF)

Micha T. Maeder, Peter Rickenbacher, Hans Rickli et al. · European Journal of Heart Failure · 2013 · 73 citations · Full text

Ultrathin Strut Biodegradable Polymer Sirolimus‐Eluting Stent Versus Durable‐Polymer Everolimus‐Eluting Stent for Percutaneous Coronary Revascularization: 2‐Year Results of the BIOSCIENCE Trial

Rainer Zbinden, Raffaele Piccolo, Dik Heg et al. · Journal of the American Heart Association · 2016 · 68 citations · Full text

Colour coded duplex sonography in suspected deep vein thrombosis of the leg.

Joanne Schindler, Miroslav Kaiser, Anna Maria Gerber et al. · BMJ · 1990 · 49 citations · Full text

Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

Edoardo Camenzind, Eric Boersma, William Wijns et al. · European Heart Journal · 2014 · 49 citations · Full text